ASPL-TFE3 RCC was diagnosed in 6 cases, which showed dual-fusion signals in the ASPL-TFE3 dual-fusion FISH assay, and the other 16/22 cases and control groups were negative. The gene discussed is ASPSCR1; the disease is renal cell carcinoma.